Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
12/10/2003 | EP1368045A1 Process for obtention of decoctions of vitis labrusca and vitis vinifera skins |
12/10/2003 | EP1368041A1 Amphotericin b aqueous composition |
12/10/2003 | EP1368040A2 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
12/10/2003 | EP1368038A1 Methods for the administration of amifostine and related compounds |
12/10/2003 | EP1368019A1 Esmolol formulation |
12/10/2003 | EP1368016A1 Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt |
12/10/2003 | EP1368008A1 Transdermal therapeutic system for the administration of partial dopamine-d2 agonists |
12/10/2003 | EP1368007A1 Coating and binding agent for pharmaceutical formulations with improved storage stability |
12/10/2003 | EP1368006A1 Novel modified released formulation |
12/10/2003 | EP1368005A2 Chronotherapeutic dosage forms |
12/10/2003 | EP1368004A2 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine |
12/10/2003 | EP1368003A1 Methods and compositions for reducing the taste of pharmaceutically active agents |
12/10/2003 | EP1368001A2 Pharmaceutical formulation comprising bicalutamide |
12/10/2003 | EP1368000A2 Chronotherapeutic dosage forms containing glucocorticosteroid |
12/10/2003 | EP1367999A2 Water soluble and palatable complexes |
12/10/2003 | EP1367997A1 Injectable water-in-oil emulsions |
12/10/2003 | EP1367996A1 Sustained-release suspension of ceftiofur hydrochloride |
12/10/2003 | EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
12/10/2003 | EP1367994A2 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors |
12/10/2003 | EP1367982A2 Hair follicle neogenesis by injection of follicle progenitor cells |
12/10/2003 | EP1367981A2 Pearlescent agent |
12/10/2003 | EP1367980A2 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides |
12/10/2003 | EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
12/10/2003 | EP1276466B1 Directly compressed solid dosage particles |
12/10/2003 | EP1154775B1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol |
12/10/2003 | EP1144420B1 Sulfated phosphatidylinositols, their preparation and use |
12/10/2003 | EP1124582B1 Preservative system for topically administrable pharmaceutical compositions |
12/10/2003 | EP1066058B1 Immunotoxin cocktails for the treatment of immune related diseases |
12/10/2003 | EP0889736B1 Iscom or iscom-matrix comprising a mucus targetting substance and an antigen |
12/10/2003 | EP0883400B1 Delivery system for localized administration of medicaments to the upper respiratory tract |
12/10/2003 | EP0862452B1 Stabilizing formulation for ngf |
12/10/2003 | EP0833666B1 Cytomodulating conjugates of members of specific binding pairs |
12/10/2003 | EP0781125B1 Enteric film coating compositions, method of coating therewith, and coated forms |
12/10/2003 | CN1461344A Multivalent target binding protein |
12/10/2003 | CN1461321A Lactic acid polymer and process for producing the same |
12/10/2003 | CN1461218A Therapeutic combination of amlodipine and benazepril |
12/10/2003 | CN1461214A Compositions for improving skin environment and clothes thereof |
12/10/2003 | CN1461212A Hydrogel-driven drug dosage form |
12/10/2003 | CN1461211A Microparticles for pulmonary administation |
12/10/2003 | CN1461210A Preparation of vitamin emulsions and concentrates thereof |
12/10/2003 | CN1461207A Vaginal delivery of bisphosphonates |
12/10/2003 | CN1461188A Material for inproving living environment, and building material, laying material and spraying agent using the same |
12/10/2003 | CN1460486A Propolis honey sweets and preparation process |
12/10/2003 | CN1460478A Huangyangning slow-releasing preparation |
12/10/2003 | CN1460476A Apomorphine sublingual dripping pill preparation with adjustable medicine-releasing rate |
12/10/2003 | CN1460471A Fenofibrate soft capsule and its preparation method |
12/10/2003 | CN1460470A Dichlofenac sodium slow-releasing preparation and its preparation method |
12/10/2003 | CN1460469A Preparation method of aspirin microsphere |
12/10/2003 | CN1460468A Improved preparation method of high-molecular microsphere embedding protein medicine and vaccine |
12/10/2003 | CN1460467A Adriamycin liposome hydrochloride for injection |
12/10/2003 | CN1130374C Synthetic peptide analogs of lung surfactant protein SP-C |
12/10/2003 | CN1130310C Improved method for preparing low-concentration polyaluminosilicate microgels |
12/10/2003 | CN1130227C Viral agent associated with mystery swine disease |
12/10/2003 | CN1130224C Low sugar content, stabilized, albumin-free recombinant coagulation factor preparation |
12/10/2003 | CN1130223C Pharmaceutical formulation containing growth hormone, amino acid and non-ionic detergent |
12/10/2003 | CN1130203C Injectable formulations of avermectins and milbemycins |
12/10/2003 | CN1130197C Implanted slow-releasing antiseptic preparation and its preparing method |
12/10/2003 | CN1130196C Preparation and method of stabilizing biological matericals by non-freezing drying method |
12/10/2003 | CN1130195C Nanoemulsion based on ethoxylated fatty ether or ethoxylated fatty ester, and use thereof |
12/10/2003 | CN1130171C Stretchable hood utensil containing stretchable adhesive matrix at least in moisture state |
12/10/2003 | CN1130123C Low PH acidic composition |
12/09/2003 | US6660810 Non cross-linked block polyetherester, preparation and uses |
12/09/2003 | US6660776 For use during dental/medical procedures to protect sensitive mouth tissue from latex glove; flavored to prevent unpleasant aftertaste associated with petrolatum |
12/09/2003 | US6660768 Parasiticidal compositions and methods of use |
12/09/2003 | US6660743 Improved stability |
12/09/2003 | US6660729 Particle-forming compositions containing fused pyrrolocarbazoles |
12/09/2003 | US6660525 Therapeutic liposome composition and method |
12/09/2003 | US6660468 Vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction |
12/09/2003 | US6660382 Process for manufacturing coated granules with masked taste and immediate release of the active principle |
12/09/2003 | US6660302 For pharmaceuticals and confectionaries; gum acacia, hydroxypropyl methylcellulose, propylene glycol plasticizer |
12/09/2003 | US6660301 Injectable microspheres for dermal augmentation and tissue bulking |
12/09/2003 | US6660299 Treating a bacterial infection in a human by administering a specified high dosage of amoxycillin over given time |
12/09/2003 | US6660298 Acidulant and a water dispersible polymer to solubilize sufficient paroxetine hydrochloride |
12/09/2003 | US6660296 Neutral granular support coated with an active layer comprising: Diltiazem or a salt, a surfactant, and a binder, and a layer which ensures sustained release of the active principle |
12/09/2003 | US6660293 Carotenoids; vitamins E, D, & C; thiamine; riboflavin; niacin; folic acid; pyridoxine; biotin; pantothenic acid; cobalamin; magnesium; manganese; zinc; selenium; chromium; copper; alpha lipoic acid; and lutein; added iron free |
12/09/2003 | US6660286 Emulsion vehicle for poorly soluble drugs |
12/09/2003 | US6660279 Stability for injection solutions |
12/09/2003 | US6660278 Fatty acid ester of diglycerol as a carrier highly efficient in solubilizing or dispersing biologically active materials |
12/09/2003 | US6660267 Prevention and treatment of sepsis |
12/09/2003 | US6660264 Treatment of intracellular infection |
12/09/2003 | US6660255 Inhibition of gene transcription by polyamide DNA-binding ligands |
12/09/2003 | US6660252 Low emulsifier multiple emulsions |
12/09/2003 | US6660251 Galenic formulation containing biotin |
12/09/2003 | US6660249 Inhalable dry powder aztreonam for treatment and prevention of pulmonary bacterial infections |
12/09/2003 | US6660248 Water solubility; medical diagnosis |
12/09/2003 | US6660247 Multiple stimulus reversible hydrogels |
12/09/2003 | US6660192 Molded waveguides |
12/09/2003 | US6659985 Method to use transdermal administration of androgens to the adnexa of the eye |
12/09/2003 | CA2376833C Oxidatively stable, long-chain ethyl ester emollients |
12/09/2003 | CA2306103C Novel once-a-day controlled release sulfonylurea formulation |
12/09/2003 | CA2301649C Burn treatment composition |
12/09/2003 | CA2227298C Paroxetine controlled release compositions |
12/09/2003 | CA2171462C Compounds for the prevention and treatment of helminth infections |
12/09/2003 | CA2106492C Herpes simplex vaccine comprising hsv glycoprotein gd and 3 deacylated monophosphoryl lipid a |
12/04/2003 | WO2003100081A2 Biologically active maleamic acid derivatives with labile amide bonds |
12/04/2003 | WO2003100042A1 Method for assembling sub units into capsoides |
12/04/2003 | WO2003100033A2 ANTI-αvβ6 ANTIBODIES |
12/04/2003 | WO2003099992A2 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
12/04/2003 | WO2003099991A2 Glp-1 gene delivery for the treatment of type 2 diabetes |
12/04/2003 | WO2003099830A2 Cardiolipin compositions, methods of preparation and use |